Cannabis Report
Home > Boards > US Listed > Biotechs >

Progenics Pharmaceuticals Inc. (PGNX)

PGNX RSS Feed
Add PGNX Price Alert      Hide Sticky   Hide Intro
Moderator: ronpopeil
Search This Board: 
Last Post: 6/13/2018 6:08:20 AM - Followers: 64 - Board type: Free - Posts Today: 0

http://www.progenics.com/

http://finance.yahoo.com/q/ks?s=PGNX

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for the treatment of unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States. It primarily focuses on the areas of gastroenterology, virology, and oncology. The company's development programs and product candidates include methylnaltrexone-subcutaneous, which completed Phase 3 clinical trial for the treatment of opioid-induced constipation; methylnaltrexone-intravenous, which is under Phase 3 clinical trial for the management of post-operative ileus; and Methylnaltrexone-Oral, a Phase 2 clinical trial oral form for the treatment of opioid-induced constipation. It is also developing PRO 140 Phase 1b clinical trial, designed to block HIV infection by inhibiting virus-cell binding; ProVax, a vaccine product candidate for the prevention of HIV infection or therapeutic treatment for HIV-positive individuals; and GMK Vaccine, a therapeutic vaccine, which is in Phase 3 clinical trial for the prevention of recurrence of melanoma. In addition, the company engages in a research program to discover treatments for hepatitis C, a chronic liver disease that block viral entry into cells. Further, Progenics Pharmaceuticals, through a joint venture with Cytogen Corporation, is developing in vivo immuno-therapies for treatment of prostate cancer, including a human monoclonal antibody-drug conjugate directed against prostate-specific membrane antigen (PSMA). The company's PSMA vaccine is in Phase 1 clinical testing. It has a collaboration agreement with Wyeth Pharmaceuticals to develop and commercialize subcutaneous, intravenous, and oral forms of methylnaltrexone. The company was incorporated in 1986 and is based in Tarrytown, New York.





 

Cannabis Report
PGNX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PGNX News: Current Report Filing (8-k) 06/14/2018 04:05:07 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/14/2018 02:39:38 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/14/2018 02:39:10 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/14/2018 02:39:10 PM
PGNX News: Statement of Changes in Beneficial Ownership (4) 06/14/2018 02:39:10 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#707   $PGNX could spike hard any day now. Sage7243 06/13/18 06:08:20 AM
#706   I like this ticker! Sage7243 05/10/18 12:15:53 PM
#705   Summary Judgment Granted Upholding the Validity of Formulation vinmantoo 05/03/18 01:06:19 AM
#704   Summary Judgment Granted Upholding the Validity of Formulation ronpopeil 05/02/18 08:29:17 PM
#703   Bought my first taste back since selling last ER Zilla 04/30/18 08:08:33 PM
#702   Yeah it’s really crazy how similar the stories ronpopeil 03/23/18 02:13:40 PM
#701   Ron, that scenario for PGNX would suit me fine. vinmantoo 03/23/18 01:46:58 PM
#700   Progenics Pharmaceuticals (PGNX unch) plunged over 19% in vinmantoo 03/23/18 01:45:59 PM
#699   PGNX maintained with a strong buy rating at ronpopeil 03/23/18 09:49:33 AM
#698   it's frustrating but this actually reminds me so ronpopeil 03/23/18 09:48:21 AM
#697   Pretty high penalty in the stock price just conix 03/23/18 09:42:51 AM
#696   PGNX is one frustrating stock. No approval is vinmantoo 03/23/18 01:08:22 AM
#695   Progenics Pharmaceuticals to Present at the 17th Annual ronpopeil 03/21/18 08:56:31 AM
#694   https://ih.advfn.com/p.php?pid=nmona&article=76976880&symbol=PGNX ronpopeil 03/19/18 09:03:12 AM
#693   Ron, that for that very positive article. It vinmantoo 03/16/18 12:07:31 AM
#692   Ron, that for that very positive article. It vinmantoo 03/16/18 12:05:56 AM
#691   ? https://seekingalpha.com/article/4156751-progenics-just-beginning? ronpopeil 03/15/18 05:51:34 PM
#690   thank you vin. i picked some shares up ronpopeil 03/12/18 01:39:19 PM
#689   Ron, vinmantoo 03/12/18 01:23:57 PM
#688   What’s the likelihood of approval? Market size? ronpopeil 03/10/18 09:35:11 PM
#687   This one looks good ronpopeil 03/10/18 09:33:09 PM
#686   Now that is what I call a nice vinmantoo 03/08/18 04:48:42 PM
#685   Back to 6 Zilla 02/18/18 06:20:45 PM
#684   from 6.75 down to 5.50 in 5 trading Zilla 02/01/18 02:43:11 PM
#683   PGNX looking great in the long run. vinmantoo 01/06/18 02:51:13 PM
#682   Was looking at 2019 10s. But dilution is Jumpinjackas 01/06/18 07:40:33 AM
#681   PGNX looking great in the long run. Analysts keithbear 01/05/18 09:39:02 AM
#680   Well look what today brought ya Awl416 12/29/17 08:51:12 AM
#679   Today was the 2nd time I've traded my Zilla 12/21/17 04:25:10 PM
#678   About a month ago the whole day was Zilla 12/17/17 07:31:45 PM
#677   Volume really picking up and roller coaster ups vinmantoo 12/17/17 04:54:58 PM
#676   Volume really picking up and roller coaster ups Zilla 12/17/17 02:45:28 PM
#675   https://seekingalpha.com/article/4104266-progenics-fda-delay-just-flesh-wound Inoviorulez 09/05/17 05:24:23 PM
#674   It's almost that time. +10% short interest H8ster 08/28/17 03:12:04 PM
#673   We might have the beginnings of a turnaround. oxnous 08/08/17 11:42:18 PM
#672   I am still in PGNX. Man, Relistor sales vinmantoo 08/03/17 08:02:33 PM
#671   Still in PGNX? Tough to watch this on oxnous 08/03/17 01:21:42 PM
#670   News is needed with PGNX oxnous 07/11/17 01:24:56 PM
#669   What a rough couple of weeks for PGNX vinmantoo 05/05/17 12:15:58 AM
#668   Just bought another 600 shares at 8.35 DorseyE 05/02/17 08:32:06 AM
#667   Just bought another 600 shares at 8.35 DorseyE 05/02/17 08:32:06 AM
#666   Just bought 2k @8.00.... DorseyE 05/01/17 08:47:40 AM
#665   Short Interest as of 4/13/2017...... 7,977,161 according to DorseyE 04/25/17 08:02:41 PM
#664   Progenics Moves Ahead Towards NDA Filing For Azedra DorseyE 04/22/17 12:49:52 AM
#663   Progenics (NASDAQ:PGNX) has declined about 7% despite meeting DorseyE 04/07/17 02:35:31 PM
#662   The markets are talking, anyone know what it's saying? DorseyE 04/05/17 04:14:00 PM
#661   WOW, never expected this! DorseyE 04/04/17 01:29:30 PM
#660   Short Interest as of 3/15/2017..... I wonder what DorseyE 03/30/17 07:14:12 PM
#659   Bought 1500 shares at 9.21 today! DorseyE 03/30/17 05:21:41 PM
#658   Short Interest DorseyE 03/09/17 08:39:36 PM
PostSubject